We use cookies to enhance your browsing experience, serve personalised ads or content, and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Cookie Policy

ORTEXORTEX News
Tracking MLYS? Get live short interest, options flow, and signals on ORTEX.Sign up free →
ML

Mineralys Therapeutics, Inc. (MLYS) short interest & options flow

NASDAQ

Mineralys Therapeutics heads into its November 11 earnings report with short sellers maintaining meaningful pressure and the stock still down sharply from recent highs, as investors wait on a commercial and regulatory update for lorundrostat. Short interest in MLYS has tightened into the print. At nearly 9.8% of the free float, the short position is substantial for a clinical-stage…

$15.81+3.13% 1d+1.67% 1w-32.35% 1mClose: 9 Nov 2026
Cost to borrow
Low
Live CTB on ORTEX →
Availability
High
Live availability on ORTEX →
Market cap
$1.40B
Next earnings
11 Nov 2026
See the full picture on ORTEX →Live short interest, options flow, signals, 13F filings, and more.

Key data as of 10 Nov 2026

ORTEX chart of Mineralys Therapeutics, Inc. (MLYS) share price and short interest (% of free float), six months to November 9, 2026

MLYS news and analysis

RSS

No long-form analysis yet for MLYS. Pulse alerts and the live data picture are available on ORTEX.

Open MLYS on ORTEX →

Want the live picture for MLYS?

Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for MLYS — free to start on ORTEX.

Sign up for free →Open MLYS on ORTEX